Genetic deletion of AEG-1 prevents hepatocarcinogenesis

Cancer Research

Volumn 74, Issue 21, 2014, Pages 6184-6193

  Robertson, Chadia L ^a   Srivastava, Jyoti ^a   Siddiq, Ayesha ^a   Gredler, Rachel ^a   Emdad, Luni ^a   Rajasekaran, Devaraja ^a   Akiel, Maaged ^a   Shen, Xue Ning ^a   Guo, Chunqing ^a   Giashuddin, Shah ^b   Wang, Xiang Yang ^a   Ghosh, Shobha ^c   Subler, Mark A ^a   Windle, Jolene J ^a,d   Fisher, Paul B ^a,c,d   Sarkar, Devanand ^a,c,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DIETHYLNITROSAMINE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STAT3 PROTEIN; CELL ADHESION MOLECULE; MTDH PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EPIGENETICS; GENE DELETION; GENE FUNCTION; GENE INACTIVATION; IN VIVO STUDY; INFLAMMATORY DISEASE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LUNG METASTASIS; MACROPHAGE; METASTASIS INHIBITION; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE AEG 1; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT; ANIMAL; CARCINOGENESIS; CHEMICALLY INDUCED; DRUG RESISTANCE; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER TUMOR; LUNG TUMOR; METABOLISM; PATHOLOGY; SECONDARY;

ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; DRUG RESISTANCE, NEOPLASM; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84910002776     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-1357     Document Type: Article

References (39)

1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365: 1118-27.
2. Berasain C, Castillo J, Perugo rria MJ, Latasa MU, Prieto J, Avila MA. Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 2009;1155:206-21.
3. Pikarsky E, Porat RM, Stein I, Abramovitch R, Ami t S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6.
4. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000;18:621-63.
5. Liu P, Kimmoun E, Legrand A, Sauvanet A, Degott C, Lardeux B, et al., Activation of NF-kappa B, AP-1 and STAT transcr iption factors is a frequent and early event in human hepatocellular carcinomas, J Hepatol, 2002, 37, 63-71.
6. Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS, et al. Constitutiv e activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 2000;89:2274-81.
7. Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, Sheen IS, et al. Activation of nuclear fact or kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000;31:656-64.
8. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, Broxtermann M, et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 2009;50:1773-82.
9. Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 2009;50:1258-66.
10. Kim HR, Lee SH, Jung G. The hepatitis B viral X protein activates NFkappaB signaling pathway through the up-regulation of TBK1. FEBS Lett 2010;584:525-30.
11. Lu B, Guo H, Zhao J, Wang C, Wu G, Pang M, et al. Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-kappaB activation, in hepatocell ular carcinoma. Gastroenterology 2010;139:2183-94 e5.
12. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology 2006;130:1886-900.
13. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015-25.
14. Haybaeck J, Zeller N, Wolf MJ, Weber A, Wagner U, Kurrer MO, et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 2009;16:295-308.
15. Maed a S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005;121: 977-90.
16. Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007;11: 119- 32.
17. He G, Yu GY, Temkin V, Ogata H, Kuntzen C, Sakurai T, et al. Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cance r Cell 2010;17:286-97.
18. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expre ssion. Cell 2010;140:197-208.
19. Sakurai T, He G, Matsuzawa A, Yu GY, Maeda S, Hardiman G, et al. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carc inogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008;14:156-65.
20. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007;317:121-4.
21. Sarkar D, Fisher PB. AEG-1/MTDH/LYRIC: clinical significance. Adv Cancer Res 2013;120:39-74.
22. Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009;119:465-77.
23. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009; 15:9-20.
24. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004;5:365-74.
25. Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche H, Sarkar D, et al. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A 2009;106:21300-5.
26. Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB., Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc, Proc Natl Acad Sci USA, 2006, 103:17390-5.
27. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007;27:55-76.
28. He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012;31:3357-69.
29. Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, et al. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2011;17: 7294-302.
30. Gong Z, Liu W, You N, Wang T, Wang X, Lu P, et al. Prognostic significance of metadherin overexpression in hepatitis B virus-related hepatocellular carcinoma. O ncol Rep 2012;27:2073-9.
31. Yoo BK, Gredler R, Vozhilla N, Su ZZ, Chen D, Forcier T, et al. Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci U S A 2009;106:12938-43.
32. Srivastava J, Siddiq A, Emdad L, Santhekadur P, Chen D, Gredler R, et al. Astrocyte elevated gene-1 (AEG-1) promotes hepatocarcinogenesis: novel insights from a mou se model. Hepatology 2012;56: 1782-91.
33. Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K, et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 2006;66:1509-16.
34. Sarkar D, Park ES,Emdad L, Lee SG, Su ZZ, Fisher PB. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 2008;68:1478-84.
35. Alexia C, Poalas K, Carvalho G, Zemirli N, Dwyer J, Dubois SM, et al. The endoplasmic reticulum acts as a platform f or ubiquitylated components of nuclear factor kappaB signaling. Sci Signal 2013;6: 79.
36. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB. Astrocyte elevated gene-1 activates cell su rvival pathways through PI3K-Akt signaling. Oncogene 2008;27:1114-21.
37. Thirkettle HJ, Girling J, Warren AY, Mills IG, Sahadevan K, Leung H, et al. LYRIC/AEG-1 is targeted to differ ent subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin Cancer Res 2009;15:3003-13.
38. Andreakos E, Williams RO, Wales J, Foxwell BM, Feldmann M. Ac tivation of NF-kappaB by the intracellular expression of NF-kappaBinducing kinase acts as a powerful vaccine adjuvant. Proc Natl Acad Sci U S A 2006;103:14459-64.
39. Khda II, Koide N,NomanAS, Dagvadorj J , Tumurkhuu G, Naiki Y, et al. Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling. Immunology 2009;128:e700-6.